Re-evaluating early high-frequency oscillatory ventilation in moderate-to-severe pediatric ARDS: evidence from a

Feifan Jin1, Ziqing Quan1, Hongxing Dang1

  • 1Department of PICU Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, China International Science and Technology Cooperation Base of Child Development and Critical Disorders, Chongqing, China.

Frontiers in Medicine
|April 10, 2026
PubMed

Insights

High-frequency oscillatory ventilation (HFOV) may increase mortality in pediatric acute respiratory distress syndrome (PARDS) compared to conventional mechanical ventilation (CMV). This study suggests CMV offers better survival outcomes for moderate-to-severe PARDS patients.

Area of Science:

  • Pediatric Critical Care Medicine
  • Respiratory Medicine
  • Mechanical Ventilation Strategies

Background:

  • Pediatric acute respiratory distress syndrome (PARDS) has a high mortality rate in pediatric intensive care units (PICUs).
  • The effectiveness of early high-frequency oscillatory ventilation (HFOV) for moderate-to-severe PARDS is debated.
  • This study investigates HFOV versus conventional mechanical ventilation (CMV) in PARDS.

Purpose of the Study:

  • To compare clinical outcomes between HFOV and CMV in pediatric patients with moderate-to-severe PARDS.
  • To evaluate the impact of ventilation strategy on 28-day mortality and other relevant outcomes.
  • To utilize genetic matching for robust comparison of ventilation groups.

Main Methods:

  • Retrospective case-control study of children with moderate-to-severe PARDS in PICUs (January 2012-June 2024).
  • Analysis of a 7-day landmark cohort with sustained invasive mechanical ventilation (≥7 days).
  • Genetic matching in R software to balance baseline characteristics between HFOV and CMV groups; primary outcome: 28-day mortality.

Main Results:

  • After matching, 53 patients were in each group with balanced characteristics.
  • HFOV group showed significantly higher 28-day mortality (49.1%) compared to CMV group (28.3%, p=0.04).
  • HFOV was independently associated with increased mortality (aOR=2.47); moderate PARDS patients had lower survival with HFOV (0.41 vs. 0.82, p=0.01).

Conclusions:

  • Early HFOV may not benefit, and could increase mortality, in moderate-to-severe PARDS.
  • Conventional mechanical ventilation (CMV) was associated with lower observed 28-day mortality.
  • Further prospective studies are needed to confirm these findings regarding PARDS ventilation strategies.
Abstract

Related Concept Videos

Ventilatory Modes01:14

Ventilatory Modes

Mechanical ventilators are life-saving devices that support or replace spontaneous breathing. They deliver breaths to patients through varying methods known as ventilator modes. Understanding these modes is critical for healthcare providers managing patients with respiratory failure.
There are three ventilatory modes: full support, partial support, and spontaneous. These are described below.
Full Support Modes
Full support modes include controlled mechanical ventilation, continuous mandatory...
2.1K
Mechanical Ventilation II: Invasive Ventilation01:23

Mechanical Ventilation II: Invasive Ventilation

Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
674
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.6K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
743